Glucomet

Glucomet is a prescription medication that contains the active ingredient Metformin Hydrochloride. It is formulated for oral administration and is marketed in the European Union. As a biguanide class drug, Glucomet is used to help manage blood glucose levels in adults with type 2 diabetes mellitus, working by decreasing hepatic glucose production and enhancing peripheral insulin sensitivity.

Glucomet is indicated for the long‑term management of type 2 diabetes mellitusin adults. It may be used as monotherapy or in combination with other antidiabetic agents when diet and exercise alone are insufficient.

- Improves glycemic control as part of a comprehensive diabetes management plan. - Can be combined with insulin or other oral hypoglycemics for additive effect. - May be prescribed when lifestyle modifications fail to achieve target HbA1c. - Often used as first‑line therapy for newly diagnosed type 2 diabetes. - Suitable for patients with overweight or obesity to aid weight neutrality.

Metformin, the active component of Glucomet, can cause a range of side effects. Most are mild and transient, while a few require prompt medical attention.

Common: - Gastrointestinal upset such as nausea, abdominal discomfort, or diarrhea. - Metallic taste in the mouth. - Decreased appetite. - Mild headache. - Vitamin B12 deficiency with long‑term use.

Serious: - Lactic acidosis, a rare but life‑threatening condition. - Severe skin reactions like Stevens‑Johnson syndrome. - Persistent vomiting leading to dehydration. - Hepatic dysfunction in susceptible individuals.

Before starting Glucomet, certain health considerations should be reviewed to ensure safe use.

- Assess renal function; contraindicated in severe renal impairment. - Evaluate liver function, as hepatic disease may increase risk of lactic acidosis. - Use cautiously in patients with a history of alcohol abuse. - Monitor vitamin B12 levels during prolonged therapy. - Pregnancy category B: discuss risks and benefits with a healthcare provider. - Adjust dose in elderly patients due to altered pharmacokinetics.

Glucomet may interact with several medications, affecting its efficacy or safety profile.

Avoid: - Iodinated contrast agents used in imaging studies without appropriate discontinuation. - Cimetidine and other potent CYP450 inhibitors that may increase metformin plasma levels. - Alcohol excess, which raises the risk of lactic acidosis.

Use with caution: - Other antidiabetic drugs, especially sulfonylureas, to avoid hypoglycemia. - Diuretics and ACE inhibitors, which can affect renal function. - Corticosteroids, as they may increase blood glucose and require dose adjustments.